Janus Henderson Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49M Hold
45,700
﹤0.01% 1502
2025
Q4
$1.61M Hold
45,700
﹤0.01% 1444
2025
Q3
$1.2M Hold
45,700
﹤0.01% 1564
2025
Q2
$1.21M Hold
45,700
﹤0.01% 1524
2025
Q1
$1.17M Hold
45,700
﹤0.01% 1550
2024
Q4
$1.84M Hold
45,700
﹤0.01% 1357
2024
Q3
$2.89M Hold
45,700
﹤0.01% 1130
2024
Q2
$2.42M Buy
45,700
+4,537
+11% +$297K ﹤0.01% 1167
2024
Q1
$3.37M Hold
41,163
﹤0.01% 1040
2023
Q4
$766K Sell
41,163
-80
-0.2% -$1.05K ﹤0.01% 1780
2023
Q3
$457K Buy
41,243
+14
+0% +$200 ﹤0.01% 1968
2023
Q2
$668K Sell
41,229
-349,907
-89% -$7.33M ﹤0.01% 1830
2023
Q1
$6.52M Buy
+391,136
New +$4.04M ﹤0.01% 801
2022
Q2
Sell
-13,409
Closed -$40K 2693
2022
Q1
$40K Hold
13,409
﹤0.01% 2625
2021
Q4
$62K Buy
+13,409
New +$75.2K ﹤0.01% 2531
2018
Q4
Sell
-891,442
Closed -$15.5M 1427
2018
Q3
$15.5M Sell
891,442
-1,168,844
-57% -$13.9M 0.01% 857
2018
Q2
$19.6M Buy
+2,060,286
New +$13.7M 0.01% 806

Other funds holding VKTX